PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Presentation for Investor Webinar, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 121 Posts.
    lightbulb Created with Sketch. 31
    Oh, I am in no way defending the company, this was a complete waste of time.
    however, PAR's track record of estimations leaves nothing to be desired. if they cant get a simple timeline correct how are we supposed to trust their projection of earnings into the $B's of dollars
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.